The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers

<p>Abstract</p> <p>Background</p> <p>The evolutionary conserved cyclin-dependent kinase phosphatase hCdc14A has been shown to play potential roles in the regulation of mitotic exit and in the centrosome duplication cycle. We have recently shown that hCdc14A also can int...

Full description

Bibliographic Details
Main Authors: Li Liwu, Dixon Jack E, Hanasoge Sheela, Derheimer Frederick A, Starks Adrienne M, Paulsen Michelle T, Ljungman Mats
Format: Article
Language:English
Published: BMC 2006-06-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/5/1/25
_version_ 1811252014868332544
author Li Liwu
Dixon Jack E
Hanasoge Sheela
Derheimer Frederick A
Starks Adrienne M
Paulsen Michelle T
Ljungman Mats
author_facet Li Liwu
Dixon Jack E
Hanasoge Sheela
Derheimer Frederick A
Starks Adrienne M
Paulsen Michelle T
Ljungman Mats
author_sort Li Liwu
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The evolutionary conserved cyclin-dependent kinase phosphatase hCdc14A has been shown to play potential roles in the regulation of mitotic exit and in the centrosome duplication cycle. We have recently shown that hCdc14A also can interact with the tumor suppressor p53 both <it>in vitro </it>and <it>in vivo </it>and specifically dephosphorylates the ser315 site of p53 <it>in vitro</it>. In this study we developed antibodies against hCdc14A to investigate the expression and regulation of hCdc14A in human tissues and cancer cells.</p> <p>Results</p> <p>We show that hCdc14A is differentially expressed in human tissues and in 75 cancer cell lines examined. Treatments with the histone deacetylase inhibitor TSA, the demethylating agent 5-aza-2'-deoxycytodine or the proteasome inhibitor MG132 significantly induced expression of hCdc14A in cell lines expressing low or undetectable levels of hCdc14A. There was a strong bias for low expression of hCdc14A in cancer cell lines harboring wild-type p53, suggesting that high Cdc14A expression is not compatible with wild-type p53 expression. We present evidence for a role for hCdc14A in the dephosphorylation of the ser315 site of p53 <it>in vivo </it>and that hCdc14A forms a complex with Cdk1/cyclin B during interphase but not during mitosis.</p> <p>Conclusion</p> <p>Our results that hCdc14A is differentially expressed in human cancer cells and that hCdc14A can interact with both p53 and the Cdk1/cyclin B complex may implicate that dysregulation of hCdc14A expression may play a role in carcinogenesis.</p>
first_indexed 2024-04-12T16:28:32Z
format Article
id doaj.art-a54169db4a9e41d0b51fdb22841800fc
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-04-12T16:28:32Z
publishDate 2006-06-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-a54169db4a9e41d0b51fdb22841800fc2022-12-22T03:25:16ZengBMCMolecular Cancer1476-45982006-06-01512510.1186/1476-4598-5-25The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancersLi LiwuDixon Jack EHanasoge SheelaDerheimer Frederick AStarks Adrienne MPaulsen Michelle TLjungman Mats<p>Abstract</p> <p>Background</p> <p>The evolutionary conserved cyclin-dependent kinase phosphatase hCdc14A has been shown to play potential roles in the regulation of mitotic exit and in the centrosome duplication cycle. We have recently shown that hCdc14A also can interact with the tumor suppressor p53 both <it>in vitro </it>and <it>in vivo </it>and specifically dephosphorylates the ser315 site of p53 <it>in vitro</it>. In this study we developed antibodies against hCdc14A to investigate the expression and regulation of hCdc14A in human tissues and cancer cells.</p> <p>Results</p> <p>We show that hCdc14A is differentially expressed in human tissues and in 75 cancer cell lines examined. Treatments with the histone deacetylase inhibitor TSA, the demethylating agent 5-aza-2'-deoxycytodine or the proteasome inhibitor MG132 significantly induced expression of hCdc14A in cell lines expressing low or undetectable levels of hCdc14A. There was a strong bias for low expression of hCdc14A in cancer cell lines harboring wild-type p53, suggesting that high Cdc14A expression is not compatible with wild-type p53 expression. We present evidence for a role for hCdc14A in the dephosphorylation of the ser315 site of p53 <it>in vivo </it>and that hCdc14A forms a complex with Cdk1/cyclin B during interphase but not during mitosis.</p> <p>Conclusion</p> <p>Our results that hCdc14A is differentially expressed in human cancer cells and that hCdc14A can interact with both p53 and the Cdk1/cyclin B complex may implicate that dysregulation of hCdc14A expression may play a role in carcinogenesis.</p>http://www.molecular-cancer.com/content/5/1/25
spellingShingle Li Liwu
Dixon Jack E
Hanasoge Sheela
Derheimer Frederick A
Starks Adrienne M
Paulsen Michelle T
Ljungman Mats
The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers
Molecular Cancer
title The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers
title_full The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers
title_fullStr The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers
title_full_unstemmed The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers
title_short The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers
title_sort p53 targeting human phosphatase hcdc14a interacts with the cdk1 cyclin b complex and is differentially expressed in human cancers
url http://www.molecular-cancer.com/content/5/1/25
work_keys_str_mv AT liliwu thep53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT dixonjacke thep53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT hanasogesheela thep53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT derheimerfredericka thep53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT starksadriennem thep53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT paulsenmichellet thep53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT ljungmanmats thep53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT liliwu p53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT dixonjacke p53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT hanasogesheela p53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT derheimerfredericka p53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT starksadriennem p53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT paulsenmichellet p53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers
AT ljungmanmats p53targetinghumanphosphatasehcdc14ainteractswiththecdk1cyclinbcomplexandisdifferentiallyexpressedinhumancancers